Trial Profile
Randomized-Double Blind Trial to Assess the Incidence and Clinical Relevance of Heparin-Induced Thrombocytopenia (HIT) Antibodies in Trauma Patients Treated With Unfractionated or Low-Molecular Weight Heparin, the HIT-TRAP Trial
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 Jan 2017
Price :
$35
*
At a glance
- Drugs Certoparin sodium (Primary) ; Heparin
- Indications Thrombosis
- Focus Adverse reactions
- Acronyms HIT-TRAP
- 01 Nov 2006 New trial record.